On March 6, 2023 Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, reported that it will participate in TD Cowen’s 43rd Annual Health Care Conference (Press release, Novavax, MAR 6, 2023, View Source [SID1234628211]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details:

Fireside Chat

Date:

Wednesday, March 8, 2023

Time:

9:50 – 10:20 a.m. Eastern Standard Time (EST)

Location:

Boston Marriott Copley Place in Boston, Massachusetts

Moderator:

Georgi Yordanov, Equity Research Analyst – Biotechnology

Novavax participant:

John Trizzino, Chief Commercial Officer and Chief Business

Officer

Conference

Event:

Investor Meetings

Date:

Wednesday, March 8, 2023

Recordings
A replay of the recorded fireside session will be available through the Events & presentations page of the Company’s website at ir.novavax.com for 90 days from the date of the conference.